Menu

NovoCure Limited NVCR

Full chart Compare
Set alert

Price alert · NVCR

All alert types
13.28 USD -0.27 (-1.99%)

At closeNov 6, 2026, 4:48 PM EST

13.28 0.00 0.00%

After hours · Nov 6, 4:48 PM ET

13.06 Day range 13.59
10.03 52-week range 19.99
YTD
+2.71%
1 year
+17.83%

Revenue & Expenses

Revenue → Gross Profit: $488.47MGross Profit → Expenses: $488.47MRevenue → Cost of Revenue: $166.88MExpenses → Selling, General & Admin: $417.73MExpenses → Research & Development: $224.54MNet Loss → Expenses: $136.23MGross Profit$488.47MNet Loss$136.23MCost of Revenue$166.88MExpenses$624.70MSelling, General & Admin$417.73MResearch & Development$224.54MRevenue$655.35M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NVCR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
655.35M605.22M509.34M537.84M535.03M
488.47M468.04M381.06M422.97M420.15M
-153.80M-170.50M-232.87M-89.52M-44.33M
-136.23M-168.63M-207.04M-92.53M-58.35M
-1.22-1.56-1.95-0.88-0.56
NVCR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
103.39M166.09M242.56M115.83M209.61M
804.33M1.24B1.15B1.19B1.14B
463.86M880.61M783.63M750.48M729.00M
236.69M675.43M596.24M584.27M575.21M
340.47M360.18M362.50M441.17M410.49M
NVCR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-49.03M-26.37M-73.34M30.79M82.76M
437.28M-140.24M184.15M-139.96M-144.83M
-451.34M90.31M15.79M15.49M25.70M
-26.65M-42.85M-27.09M-21.36M-24.17M
-62.70M-76.47M126.73M-93.78M-36.56M